Trifarma S.P.A on Health Canada Inspection List
Trifarma S.p.A. Fails EDQM Inspection
Alchymars ICM SM Private Limited Placed on FDA Import Alert List
An Indian drugmaker has stopped halted production of a couple of APIs for the U.S. after FDA inspectors found it was falsifying data at its manufacturing complex near Tamil Nadu, India. That was just the beginning of the problems.
Alchymars ICM SM Private Limited Receives FDA Warning Letter
The government is looking to promote domestic pharma companies' tieups with bulk drug makers in Italy to cut dependence on China for pharmaceutical ingredients.